IO Biotech
A single pivotal trial narrowly missing statistical significance can be as fatal to a biotech's near-term viability as an outright failure, especially when regulators require an entirely new registrational study.
IO Biotech was a Biotechnology startup founded in 2014 in USA. It raised $170M before collapsing in 2026 — 12 years of runway burned. IdeaProof's AI Failure Score: 6/100, driven by filed for chapter 7 bankruptcy. The shutdown affected employees, investors, and the broader Biotechnology ecosystem. This case study breaks down the timeline, root causes, competitors that won, and replicable lessons for founders validating similar ideas today.
Why did IO Biotech fail?
IO Biotech failed in 2026 after 12 years of operation, losing $170M in raised capital. The root cause was filed for chapter 7 bankruptcy. Key lesson: A single pivotal trial narrowly missing statistical significance can be as fatal to a biotech's near-term viability as an outright failure, especially when regulators require an entirely new registrational study.
2014 → 2026
$170M
Biotechnology
USA
IdeaProof AI Failure Score
What Happened: The Timeline
2025-08
Phase 3 IOB-013 trial narrowly misses PFS significance
2025-09
FDA recommends against BLA; company restructures
Root Causes
IO Biotech, a New York-based clinical-stage biotech, developed Cylembio, a therapeutic cancer vaccine to combine with Merck's Keytruda as first-line treatment for advanced melanoma. The pivotal Phase 3 trial IOB-013 evaluated Cylembio+Keytruda vs Keytruda alone. In August 2025, IO Biotech announced the trial showed clinically meaningful improvement in progression-free survival but 'narrowly missed' statistical significance. Despite this, IO Biotech initially pursued FDA approval. In September 2025, following a pre-BLA meeting, the FDA recommended against a BLA submission, urging IO Biotech to design a new registrational study. IO Biotech announced restructuring and workforce reduction.
Key Lessons Learned
Frequently Asked Questions
Sources & Confidence
Every data point is tagged with its source type and our confidence in it. How we grade sources.
Could This Failure Have Been Prevented?
IdeaProof's AI validates market demand, competitive positioning, and business model viability in minutes — catching the exact issues that sank IO Biotech.